[Machine learning-based prediction model for caries in the first molars of 9-year-old children in Suzhou]. [PDF]
Hua Xi Kou Qiang Yi Xue Za ZhiChen L, Wang X, Zhu K, Ren K, Wu Z.
europepmc +1 more source
[Exercise-induced hyperinsulinism: genetic basis and clinical management]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiZhang QT, Hou L.
europepmc +1 more source
[A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia]. [PDF]
Zhonghua Xue Ye Xue Za ZhiXie X +6 more
europepmc +1 more source
[Zeta-focal bone lengthening for bone defects after fracture-related infection: a two-case based research]. [PDF]
Zhongguo Xiu Fu Chong Jian Wai Ke Za ZhiAihemaitijiang Y +5 more
europepmc +1 more source
[Simultaneous determination of selinexor， posaconazole， venetoclax， and voriconazole in human plasma using ultra-high performance liquid chromatography-tandem mass spectrometry]. [PDF]
Se PuXiao X, Li Y, Hu JF, Wan Q, Peng HW.
europepmc +1 more source
[BK virus nephropathy after allogeneic hematopoietic stem cell transplantation: a case report and literature review]. [PDF]
Zhonghua Xue Ye Xue Za ZhiZhang WL +11 more
europepmc +1 more source
[Application of umbilical cord mesenchymal stem cells in the treatment of severe immune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation in children]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiZhang B, Luan Z, Tang XF, Wu NH.
europepmc +1 more source
[Construction of a prognosis forecasting model for immuno-therapy response in cancer patients by integrating routine clinical parameters and tumor mutational burden]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanZhu X, Hao S, Cheng Z, Fang W.
europepmc +1 more source
[Efficacy and safety of venetoclax combined with tyrosine kinase inhibitors and reduced-dose chemotherapy in 13 cases of minimal residual disease-positive and relapsed/refractory Ph(+) acute lymphoblastic leukemia]. [PDF]
Zhonghua Xue Ye Xue Za ZhiAi H, Liang TT, Wang Q, Wu HF, Yin QS.
europepmc +1 more source